Fierce Pharma Asia—MEI and Kyowa Kirin’s PI3K woes; Takeda’s dengue nod, Daiichii Sankyo’s Enhertu positivity esagonowsky Fri, 12/09/2022 – 10:43 More: Fierce Pharma Asia—MEI and Kyowa Kirin’s PI3K woes; Takeda’s dengue nod, Daiichii Sankyo’s Enhertu positivity Source: fierce
read moreSenator presses Amgen with ‘final request’ for information in tax probe kdunleavy Fri, 12/09/2022 – 09:50 More: Senator presses Amgen with 'final request' for information in tax probe Source: fierce
read moreAZ writes the ‘next chapter’ in Enhertu’s saga with head-to-head win versus Roche’s Kadcyla fkansteiner Fri, 12/09/2022 – 09:22 More: AZ writes the 'next chapter' in Enhertu's saga with head-to-head win versus Roche's Kadcyla Source: fierce
read moreFacility represents one of the largest commercial-scale operations in the world More: Catalent completes cell therapy manufacturing facilities in Belgium Source: News
read moreStudy involves candidate NVD-003 and the treatment of lower limb trauma More: Novadip reveals results from severe bone non-union trial Source: News
read moreDaiichi Sankyo walks back Yescarta marketing deal with Gilead, Kite fkansteiner Thu, 12/08/2022 – 11:16 More: Daiichi Sankyo walks back Yescarta marketing deal with Gilead, Kite Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals